Advocacy Actions
Meeting with Shanghai Emergency Management Bureau
On 28th April, Compliance and PCR working group members met Mr Cao Xi from the Shanghai Emergency Management Bureau, Hazardous Chemical Division and learned about the current practice regarding hazardous chemical management and shipping regulations.
Read moreConsultation Letter to GACC on Regulation on Registration Administration of Overseas Manufactures of Imported Foods and Administrative Measures on Safety of Import and Export Food
European Chamber sent a consultation letter to raise industry's question and share comments with GACC on Regulation on Registration Administration of Overseas Manufactures of Imported Foods and Administrative Measures on Safety of Import and Export Food.
Read moreKick-off Meeting of the Smart Energy Work Stream
In accordance with the relevant work plan of the National Energy Administration, the China-Europe Energy Innovation Cooperation (CEEI) has been divided into four fields (work streams): energy storage, hydrogen energy, smart energy and wind power. The smart energy field is jointly led by the Chinese side: State Grid Dual Innovation Demonstration Base Zhejiang Demonstration Centre (国网双创示范基地浙江示范中心) and Tsinghua Sichuan Energy Internet Research Institute (清华四川能源互联网研究院); and the European side: Engie and Schneider.
Read moreConference with the Centre for International Economic and Technology Cooperation (CIETC) on Carbon Neutrality Policy and Path in China and Europe
The European Chamber co-organised the event “Carbon Neutrality Policy and Path in China and Europe” along with the Centre for International Economic and Technology Cooperation (CIETC) of the Ministry of Industry and Information Technology (MIIT) on Monday 26th April at 14:00-17:00 at European Chamber Beijing Office.
Read moreMeeting with the Centre for Medical Device Evaluation on the Technical Guidance on the Usage of Overseas Clinical Trial Data of In Vitro Diagnostic Reagents
On 26 April, the medical device sector had a meeting with the Centre for Medical Device Evaluation on the Technical Guidance on the Usage of Overseas Clinical Trial Data of In Vitro Diagnostic Reagents.
Read moreLobby letter to NMPA about transition period in Administration of Cosmetics Labelling
The Cosmetics Desk submitted a lobby letter to NMPA about the transition period in Administration of Cosmetics Labelling.
Read moreVisit to Tianjin Development and Reform Commission
On 25 April, The Chamber Tianjin Chapter, Catherine Guo, General Manager of Tianjin Chapter paid a visit to Foreign Capital and Overseas Investment Department of Tianjin Development and Reform Commission and met with Director Ma Te. Each side introduced the responsibilities and services to foreign investment. Director Ma expressed strong willingness of further cooperation with the European Chamber Tianjin Chapter.
Read moreComments to NMPA on the Administrative Measures for Medical Device Registration (Revised Draft for Comments)
On 25 April, the medical device sector sent omments to the National Medical Products Administration on the Administrative Measures for Medical Device Registration (Revised Draft for Comments).
Read moreComments to NMPA on the Administrative Measures for In Vitro Diagnostic Reagents Registration (Revised Draft for Comments;)
On 25 April, the medical device sector sent comments to the National Medical Products Adminstration on the Administrative Measures for In Vitro Diagnostic Reagents Registration (Revised Draft for Comments).
Read moreComments to NMPA on the Administration Measures for Supervision of Medical Device Manufacturing (Revised Draft for Comments)
On 25 April, the medical device sector sent comments to the National Medical Products Administrtaion on the Administration Measures for Supervision of Medical Device Manufacturing (Revised Draft for Comments).
Read more